Neuroendocrine Tumors of the Pancreas

More documents

Recommendations

Info

$(Microsoft PowerPoint - clubnefropatolog\355a.ppt)$

Syndromic PanNENPancreatic Tumors• MEN1 11q13 20-70%• VHL 3p25 < 20%• NF1 17q11.2 < 10%• TSC1 9q34 ≈ 1%TSC2 16p13.3Prof. Dr. med. P. KomminothZürich, Switzerland
MEN1 in sporadic PanNENMutationsAllelic deletions• Insulinomas 7.7% 39%• Non-functioning 8% 75%• Gastrinomas 37% 90%• Glucagonomas 67% 75%• VIPomas 44% 80%• All 21% 68%Prof. Dr. med. P. KomminothZürich, Switzerland
Page 1 and 2:
Neuroendocrine Tumors of thePancrea
Page 4 and 5:
PanNEN: Clinical classification•F
Page 6 and 7:
PanNEN: Distribution300250Insulinom
Page 8 and 9: What do the clinicians want from us
Page 10 and 11: Prof. Dr. med. P. KomminothZürich,
Page 20 and 21: LipaseProf. Dr. med. P. KomminothZ
Page 22 and 23: Acinar cell carcinoma• Pancreas s
Page 28 and 29: Solid-pseudopapillary tumor• 1-2%
Page 32 and 33: Solid-pseudopapillary tumor• CK (
Page 36 and 37: Pancreatoblastoma• squamoid corpu
Page 38 and 39: Pancreatoblastoma• CK + (but not
Page 40 and 41: PanNEN: WHO 20041. Well-differentia
Page 42 and 43: WHO 2010• Categories for NEN:1. N
Page 44 and 45: What do the clinicians want from us
Page 48 and 49: (somatostatin)(peptide receptor rad
Page 50 and 51: ENETS TNM TNM UICC/AJCC 20102006200
Page 52 and 53: ENETS and AJCC/UICC TNM are differe
Page 56 and 57: WHOTNMTumortypeGrade&StagingBiopsie
Page 60 and 61: many chromosomesinvolvedboth gains
Page 62 and 63: cDNA expression arraySpearman 3fach
Page 64 and 65: 10 PanNEN -> genome widesequencing:
Page 66 and 67: Perren et al. unpublished dataALT:
Page 68 and 69: number of samples252015105Daxx and
Page 70 and 71: Genes and pathways alterations in P
Page 74 and 75: Questions ?Prof. Dr. med. P. Kommin
Page 76: WHO 2004 + CK19Tumor Percent specif
show all

Neuroendocrine Tumors of the Pancreas

Create successful ePaper yourself

Delete template?

Save as template?